Rifampin, Oral Contraceptives, and Pregnancy
JAMAPublished 20 September 1976
Judah L. Skolnick
Citations110
SJR quartileQ1
SJR score5.35
SNIP10.71
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
An eighth case involving a woman who became pregnant twice on this drug combination of rifampin and oral contraceptives is reported.
Abstract
Rifampin is a drug used in the treatment of tuberculosis. In the literature, there are reports of seven patients who became pregnant while taking a combination of rifampin and oral contraceptives. We report an eighth case involving a woman who became pregnant twice on this drug combination.
Keywords
Medicine
DMW - Deutsche Medizinische WochenschriftWirkung von Rifampicin auf den Menstruationszyklus und die Östrogenausscheidung bei Einnahme oraler Kontrazeptiva
89 Citations1973Lieselotte Nocke-Finck, H. Breuer +1 more
JAMARifampicin and the Pill
2 Citations1974Howard D. Cohn
The Ciba-Geigy Corporation has been aware of this situation for several months; since August 1973, the package insert for Rimactane, the company's brand of rifampicin (rifampin), has contained the precaution, "It has been reported that the reliability of oral contraceptives may be affected in some patients being treated for tuberculosis with rifampsicin."